She is also the co-PI for the Atopic Dermatitis and Vaccinia Immunization Network (ADVN) for which the primary goal is to advance clinical research in the development of safer smallpox vaccines for individuals with atopic dermatitis (AD).Dr. Kesler is also the author of Rho's Adaptive Design blog, which covers topics such as FDA preferences, regulatory concerns, biostatistical considerations, and